Perspective Therapeutics, Inc. (CATX)
USD 2.56
(3.64%)
USD 2.56
(3.64%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2022 | -14.83 Million USD | -100.76% |
| 2021 | -7.39 Million USD | -115.61% |
| 2020 | -3.42 Million USD | 1.38% |
| 2019 | -3.47 Million USD | 34.44% |
| 2018 | -5.3 Million USD | 20.87% |
| 2017 | -6.7 Million USD | -8.26% |
| 2016 | -6.18 Million USD | -40.88% |
| 2015 | -4.39 Million USD | -8.38% |
| 2014 | -4.05 Million USD | -4.18% |
| 2013 | -3.89 Million USD | -16.93% |
| 2012 | -3.32 Million USD | -13.92% |
| 2011 | -2.92 Million USD | -41.03% |
| 2010 | -2.07 Million USD | 31.24% |
| 2009 | -3.01 Million USD | 45.61% |
| 2008 | -5.53 Million USD | 25.85% |
| 2007 | -7.46 Million USD | 16.88% |
| 2006 | -8.98 Million USD | -45.99% |
| 2005 | -6.15 Million USD | 0.0% |
| 2003 | -9095.00 USD | 52.19% |
| 2002 | -19.02 Thousand USD | -150.82% |
| 2001 | -7584.00 USD | 51.29% |
| 2000 | -15.56 Thousand USD | -10.04% |
| 1999 | -14.14 Thousand USD | 8.89% |
| 1998 | -15.53 Thousand USD | 93.37% |
| 1997 | -234.32 Thousand USD | -1790.03% |
| 1996 | 13.86 Thousand USD | 100.52% |
| 1995 | -2.68 Million USD | -516.06% |
| 1994 | -436.43 Thousand USD | 75.48% |
| 1993 | -1.77 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q1 | -9.8 Million USD | 11.47% |
| 2022 Q3 | -10.65 Million USD | -243.03% |
| 2022 Q1 | -4.2 Million USD | -99.81% |
| 2022 Q2 | -3.1 Million USD | 26.21% |
| 2022 FY | - USD | -100.76% |
| 2022 Q4 | -11.07 Million USD | -4.01% |
| 2021 Q3 | -1.37 Million USD | 15.84% |
| 2021 Q1 | -2.21 Million USD | -102.65% |
| 2021 FY | - USD | -115.61% |
| 2021 Q4 | -2.1 Million USD | -53.05% |
| 2021 Q2 | -1.63 Million USD | 26.19% |
| 2020 Q3 | -762 Thousand USD | 11.29% |
| 2020 Q2 | -859 Thousand USD | -20.31% |
| 2020 Q1 | -714 Thousand USD | 39.95% |
| 2020 FY | - USD | 1.38% |
| 2020 Q4 | -1.09 Million USD | -43.44% |
| 2019 Q3 | -512 Thousand USD | 40.74% |
| 2019 FY | - USD | 34.44% |
| 2019 Q1 | -798 Thousand USD | 30.24% |
| 2019 Q2 | -864 Thousand USD | -8.27% |
| 2019 Q4 | -1.18 Million USD | -132.23% |
| 2018 Q1 | -1.48 Million USD | 36.98% |
| 2018 Q2 | -1.47 Million USD | 0.74% |
| 2018 Q3 | -1.16 Million USD | 21.02% |
| 2018 Q4 | -1.14 Million USD | 1.8% |
| 2018 FY | - USD | 20.87% |
| 2017 Q3 | -1.31 Million USD | 10.15% |
| 2017 FY | - USD | -8.26% |
| 2017 Q2 | -1.46 Million USD | 4.3% |
| 2017 Q1 | -1.53 Million USD | 17.26% |
| 2017 Q4 | -2.35 Million USD | -78.77% |
| 2016 Q1 | -1.58 Million USD | -38.62% |
| 2016 FY | - USD | -40.88% |
| 2016 Q4 | -1.85 Million USD | -35.23% |
| 2016 Q3 | -1.37 Million USD | 5.45% |
| 2016 Q2 | -1.45 Million USD | 8.58% |
| 2015 FY | - USD | -8.38% |
| 2015 Q4 | -1.14 Million USD | -0.78% |
| 2015 Q3 | -1.13 Million USD | 6.72% |
| 2015 Q2 | -1.21 Million USD | -35.76% |
| 2015 Q1 | -896.49 Thousand USD | 18.7% |
| 2014 Q2 | -812.77 Thousand USD | 11.5% |
| 2014 Q1 | -918.44 Thousand USD | 20.87% |
| 2014 Q4 | -1.1 Million USD | -30.04% |
| 2014 FY | - USD | -4.18% |
| 2014 Q3 | -847.98 Thousand USD | -4.33% |
| 2013 Q2 | -886.05 Thousand USD | 16.24% |
| 2013 FY | - USD | -16.93% |
| 2013 Q1 | -1.05 Million USD | -25.15% |
| 2013 Q4 | -1.16 Million USD | -48.56% |
| 2013 Q3 | -781.26 Thousand USD | 11.83% |
| 2012 Q1 | -1.04 Million USD | -98.11% |
| 2012 FY | - USD | -13.92% |
| 2012 Q3 | -648.35 Thousand USD | 29.34% |
| 2012 Q2 | -917.54 Thousand USD | 12.23% |
| 2012 Q4 | -845.26 Thousand USD | -30.37% |
| 2011 FY | - USD | -41.03% |
| 2011 Q3 | -768.15 Thousand USD | -3.89% |
| 2011 Q4 | -527.7 Thousand USD | 31.3% |
| 2011 Q1 | -885.51 Thousand USD | -210.05% |
| 2011 Q2 | -739.39 Thousand USD | 16.5% |
| 2010 Q1 | -643.95 Thousand USD | 19.56% |
| 2010 FY | - USD | 31.24% |
| 2010 Q2 | -1.13 Million USD | -75.82% |
| 2010 Q3 | -309 Thousand USD | 72.71% |
| 2010 Q4 | -285.6 Thousand USD | 7.57% |
| 2009 FY | - USD | 45.61% |
| 2009 Q1 | -652.31 Thousand USD | 30.99% |
| 2009 Q3 | -855.93 Thousand USD | -21.71% |
| 2009 Q4 | -800.53 Thousand USD | 6.47% |
| 2009 Q2 | -703.24 Thousand USD | -7.81% |
| 2008 Q2 | -2.21 Million USD | -85.27% |
| 2008 FY | - USD | 25.85% |
| 2008 Q1 | -1.19 Million USD | -17.15% |
| 2008 Q4 | -945.24 Thousand USD | 20.0% |
| 2008 Q3 | -1.18 Million USD | 46.66% |
| 2007 Q2 | -2.59 Million USD | -19.95% |
| 2007 Q1 | -2.15 Million USD | 14.15% |
| 2007 Q4 | -1.02 Million USD | 39.84% |
| 2007 FY | - USD | 16.88% |
| 2007 Q3 | -1.69 Million USD | 34.52% |
| 2006 Q4 | -2.51 Million USD | -31.91% |
| 2006 Q2 | -1.77 Million USD | 36.23% |
| 2006 Q1 | -2.78 Million USD | -10.7% |
| 2006 FY | - USD | -45.99% |
| 2006 Q3 | -1.9 Million USD | -7.39% |
| 2005 Q3 | -1.07 Million USD | 10.2% |
| 2005 Q2 | -1.2 Million USD | 29.73% |
| 2005 Q4 | -2.51 Million USD | -133.21% |
| 2005 FY | - USD | 0.0% |
| 2005 Q1 | -1.7 Million USD | 0.0% |
| 2004 Q2 | -3574.00 USD | 14.27% |
| 2004 Q3 | -302.04 Thousand USD | -8351.04% |
| 2004 Q1 | -4169.00 USD | 44.21% |
| 2003 Q2 | -2934.00 USD | 57.91% |
| 2003 FY | - USD | 52.19% |
| 2003 Q3 | -1593.00 USD | 45.71% |
| 2003 Q1 | -6971.00 USD | -292.95% |
| 2003 Q4 | -7472.00 USD | -369.05% |
| 2002 Q3 | -2708.00 USD | 64.23% |
| 2002 FY | - USD | -150.82% |
| 2002 Q1 | 271.00 USD | 118.3% |
| 2002 Q2 | -7570.00 USD | -2893.36% |
| 2002 Q4 | -1774.00 USD | 34.49% |
| 2001 Q2 | -1495.00 USD | 11.64% |
| 2001 Q3 | -4879.00 USD | -226.35% |
| 2001 Q4 | -1481.00 USD | 69.65% |
| 2001 Q1 | -1692.00 USD | 84.41% |
| 2001 FY | - USD | 51.29% |
| 2000 Q4 | -10.85 Thousand USD | -1012.82% |
| 2000 Q2 | -2054.00 USD | 85.41% |
| 2000 Q1 | -14.07 Thousand USD | -58558.33% |
| 2000 FY | - USD | -10.04% |
| 2000 Q3 | -975.00 USD | 52.53% |
| 1999 Q3 | -25.00 USD | -4.17% |
| 1999 FY | - USD | 8.89% |
| 1999 Q4 | -24.00 USD | 4.0% |
| 1999 Q1 | -12.57 Thousand USD | -1622.33% |
| 1999 Q2 | -24.00 USD | 99.81% |
| 1998 Q2 | -2690.00 USD | 0.0% |
| 1998 Q3 | -463.00 USD | 82.79% |
| 1998 Q4 | -730.00 USD | -57.67% |
| 1998 FY | - USD | 93.37% |
| 1997 FY | - USD | -1790.03% |
| 1996 FY | - USD | 100.52% |
| 1995 FY | - USD | -516.06% |
| 1994 FY | - USD | 75.48% |
| 1993 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Electromed, Inc. | 7.42 Million USD | 299.919% |
| Senseonics Holdings, Inc. | -48 Million USD | 69.091% |
| Catheter Precision, Inc. | -15.11 Million USD | 1.8% |
| Xtant Medical Holdings, Inc. | -6.98 Million USD | -112.457% |